These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23147764)

  • 1. Podocyte biology: a new regulator of podocytes.
    Allison SJ
    Nat Rev Nephrol; 2012 Dec; 8(12):683. PubMed ID: 23147764
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation.
    Yuan Q; Miao J; Yang Q; Fang L; Fang Y; Ding H; Zhou Y; Jiang L; Dai C; Zen K; Sun Q; Yang J
    Cell Death Dis; 2020 May; 11(5):355. PubMed ID: 32393782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.
    Tang H; Lei CT; Ye C; Gao P; Wan C; Chen S; He FF; Wang YM; Su H; Zhang C
    J Cell Mol Med; 2017 Dec; 21(12):3435-3444. PubMed ID: 28643424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.
    Mallipattu SK; Liu R; Zheng F; Narla G; Ma'ayan A; Dikman S; Jain MK; Saleem M; D'Agati V; Klotman P; Chuang PY; He JC
    J Biol Chem; 2012 Jun; 287(23):19122-35. PubMed ID: 22493483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylase KDM6B regulates human podocyte differentiation
    Guo Y; Xiong Z; Guo X
    Biochem J; 2019 Jun; 476(12):1741-1751. PubMed ID: 31138771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein half-life determines expression of proteostatic networks in podocyte differentiation.
    Schroeter CB; Koehler S; Kann M; Schermer B; Benzing T; Brinkkoetter PT; Rinschen MM
    FASEB J; 2018 Sep; 32(9):4696-4713. PubMed ID: 29694247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Podocyte Biology.
    Garg P
    Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin modulates intracellular signalling pathways that are critical for podocyte survival.
    El Zein N; Abdallah MS; Daher CF; Mroueh M; Stephan J; Bahous SA; Eid A; Faour WH
    Cell Biochem Funct; 2019 Jun; 37(4):245-255. PubMed ID: 31017709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin C is a novel mediator of podocyte and renal injury induced by hyperglycemia.
    Audzeyenka I; Rachubik P; Rogacka D; Typiak M; Kulesza T; Angielski S; Rychłowski M; Wysocka M; Gruba N; Lesner A; Saleem MA; Piwkowska A
    Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118723. PubMed ID: 32302668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
    Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
    FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte development, disease, and stem cell research.
    Yoshimura Y; Nishinakamura R
    Kidney Int; 2019 Nov; 96(5):1077-1082. PubMed ID: 31420196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tangeretin Ameliorates Glucose-Induced Podocyte Injury through Blocking Epithelial to Mesenchymal Transition Caused by Oxidative Stress and Hypoxia.
    Kang MK; Kim SI; Oh SY; Na W; Kang YH
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
    Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
    Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.
    Yao Y; Wang J; Yoshida S; Nada S; Okada M; Inoki K
    J Am Soc Nephrol; 2016 Dec; 27(12):3653-3665. PubMed ID: 27032892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocytes and the quest for precision medicines for kidney diseases.
    Mundel P
    Pflugers Arch; 2017 Aug; 469(7-8):1029-1037. PubMed ID: 28646406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear YAP localization as a key regulator of podocyte function.
    Bonse J; Wennmann DO; Kremerskothen J; Weide T; Michgehl U; Pavenstädt H; Vollenbröker B
    Cell Death Dis; 2018 Aug; 9(9):850. PubMed ID: 30154411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Developmental Trajectories of Human Podocyte Inform In Vitro Differentiation of Pluripotent Stem Cell-Derived Podocytes.
    Tran T; Lindström NO; Ransick A; De Sena Brandine G; Guo Q; Kim AD; Der B; Peti-Peterdi J; Smith AD; Thornton M; Grubbs B; McMahon JA; McMahon AP
    Dev Cell; 2019 Jul; 50(1):102-116.e6. PubMed ID: 31265809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.